TFH 2 cells associate with enhanced humoral immunity to SARS-CoV-2 inactivated vaccine in patients with allergic rhinitis

Clin Transl Med. 2022 Jan;12(1):e717. doi: 10.1002/ctm2.717.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • COVID-19 / immunology*
  • COVID-19 / prevention & control
  • COVID-19 Vaccines* / administration & dosage
  • COVID-19 Vaccines* / immunology
  • Female
  • Humans
  • Immunity, Humoral / drug effects*
  • Male
  • Prospective Studies
  • Rhinitis, Allergic / immunology*
  • SARS-CoV-2 / immunology*
  • Vaccines, Inactivated* / administration & dosage
  • Vaccines, Inactivated* / immunology

Substances

  • COVID-19 Vaccines
  • SARS-CoV-2 inactivated vaccines
  • Vaccines, Inactivated